GlobeNewswire 9/23/2025 Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
GlobeNewswire 9/22/2025 ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK
GlobeNewswire 9/19/2025 Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
GlobeNewswire 9/19/2025 CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed...
GlobeNewswire 9/17/2025 ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair
GlobeNewswire 9/11/2025 NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Cl...
GlobeNewswire 9/11/2025 Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Crea...
GlobeNewswire 9/10/2025 Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market
GlobeNewswire 9/9/2025 Xilio Therapeutics Announces Initiation of Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Ac...
GlobeNewswire 9/4/2025 ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire 9/4/2025 Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire 9/3/2025 Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes
GlobeNewswire 9/2/2025 Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guideli...
GlobeNewswire 9/2/2025 Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
GlobeNewswire 9/2/2025 Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
GlobeNewswire 8/28/2025 Gene and Oral Therapies Drive Urgency and Innovation in Retinal Care, Reshaping Ophthalmology’s Futu...
GlobeNewswire 8/28/2025 Great Place To Work Announces the 2025 Best Workplaces in Asia Representing 7.5 Million Employee Exp...
GlobeNewswire 8/25/2025 Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
GlobeNewswire 8/18/2025 Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Ri...
GlobeNewswire 8/14/2025 Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results
GlobeNewswire 8/13/2025 Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
GlobeNewswire 8/13/2025 Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
GlobeNewswire 8/7/2025 Genmab Announces Financial Results for the First Half of 2025
GlobeNewswire 8/7/2025 Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Rel...
GlobeNewswire 8/6/2025 Royalty Pharma Reports Second Quarter 2025 Results